DRG payment for male reproductive system malignant tumor surgery: analysis and recommendations on resource consumption in a tertiary hospital in China

Table 5 Costs information and t-test result of subgroups of MA13

Subgroup	Number of cases	Payment standard	Average costs	Min. costs	Max. costs	SD	CV	t value	P value
MA13a-R	674	/	64471.12	19296.08	109593.38	7754.83	0.12	0.657	0.551
MA13b-R	2144	/	64697.94	18367.34	104655.78	7834.80	0.12	0.657	0.551
MA13a-NR	668	/	25900.57	7432.71	86572.77	9005.92	0.35	9.813	< 0.001
MA13b-NR	1832	/	29246.07	4888.36	88941.62	6937.47	0.24	9.813	< 0.001
MA13	5318	55162.62	47582.98	4888.36	109593.38	19705.07	0.41	/	/

SD: standard deviation;CV: coefficient of variation. All costs are presented in Chinese Yuan (CNY). The name of DRG group: MA13, Surgery for malignant tumors of male reproductive organs, accompanied by general complications and comorbidities.MA13a-R: Age < 65 with robot-assisted surgery.MA13b-R: Age ≥ 65 with robot-assisted surgery.MA13a-NR: Age < 65 without robot-assisted surgery.MA13b-NR: Age ≥ 65 without robot-assisted surgery

ISSN: 1471-2482